Erika A. Lovas, n/a

Fred Hutchinson Cancer Center

Disclosure(s): No financial relationships to disclose

Poster(s):

• 2109 - HHV-6 and EBV Reactivation after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis: A Retrospective Cohort Study
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET